Upregulation of psoriasin/S100A7 correlates with clinical severity in patients with oral lichen planus.
Kim Natalie StolteKerstin DankerMaren WittHarald EbhardtHenrik DommischPublished in: Clinical oral investigations (2024)
Psoriasin is a putative biomarker to monitor disease severity including malignant transformation of OLP lesions. OHIP-G14 scores can be useful to monitor OHrQoL in OLP patients.